Related Experiment Videos
Future therapies for inflammatory bowel disease.
Stephen J Bickston1, Lawrence W Comerford, Fabio Cominelli
1University of Virginia Digestive Health Center of Excellence (UVA-DHCOE), MSB-2nd floor, Room 2121, Charlottesville, VA 22908-0708, USA. FC4Q@hscmail.mcc.virginia.edu
Current Gastroenterology Reports
|November 7, 2003
Summary
Inflammatory bowel disease (IBD) arises from genetic, environmental, and immune factors. Future therapies will target these domains, with genetic manipulation offering long-term treatment potential.
Area of Science:
- Gastroenterology and Immunology
- Molecular Biology
Background:
- Inflammatory bowel disease (IBD) etiology involves genetic predisposition, environmental factors, and immune system dysregulation.
- Understanding these components is crucial for developing effective treatments.
Purpose of the Study:
- To review fundamental concepts in IBD etiology.
- To comment on current and future therapeutic strategies for IBD.
Main Methods:
- Literature review of IBD pathogenesis.
- Analysis of current and emerging treatment modalities.
Main Results:
- Environmental stimuli and abnormal immune response are near-term therapeutic targets.
- Genetic manipulation presents a future avenue for IBD treatment.
Conclusions:
- IBD treatment strategies are evolving, integrating genetic, environmental, and immunological approaches.
- Future therapies will likely be personalized and target multiple etiological domains.